Novartis CEO Brushes Off Tariffs but Says Trump Pricing Controls Would Be ‘Devastating’

Vas Narasimhan said on Tuesday that if the U.S. adopts international drug pricing, all companies would have to “relook at their medium- to long-term outlook.”